Assessing the Effect of Contact Isolation on Nosocomial Colonization With ESBL-EC in German Hematology/Oncology Wards
NCT02456818 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2264
Last updated 2016-02-08
Summary
This study aims to evaluate the impact of contact isolation on the rate of hospital-acquired transmissions of ESBL-producing Escherichia coli (ESBL-EC) and the rate of colonization and infection. On the basis of this study, it will be possible to re-evaluate the need for contact isolation for patients colonized or infected with ESBL-EC.
Conditions
- Oncology [See Also, Affected System]
- Hematological Disease
- Infection Due to ESBL Escherichia Coli
Sponsors & Collaborators
-
University Hospital Tuebingen
collaborator OTHER -
Universitätsklinikum Hamburg-Eppendorf
collaborator OTHER -
University Hospital, Aachen
collaborator OTHER -
University of Cologne
lead OTHER
Principal Investigators
-
Maria JG Vehreschild, PD Dr. · university clinic of cologne
-
Oliver A Cornely, Prof Dr. · university clinic of cologne
-
Jörg J Vehreschild, PD Dr. · university clinic of cologne
-
Harald Seifert, Prof. Dr. · university clinic of cologne
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-01-31
- Primary Completion
- 2016-06-30
- Completion
- 2016-06-30
More Related Trials
-
Understanding and Modeling Reservoirs, Vehicles and Transmission of ESBL-producing Enterobacteriaceae in the Community and Long Term Care Facilities
NCT03477084 ·Status: COMPLETED
-
Fecal ESBL Resurgence During Antibiotic Treatment
NCT03206879 ·Status: TERMINATED
-
Antibiotic Stewardship and Infection Control in Patients at High Risk of Developing Infection by Clostridium Difficile, Vancomycin-Resistant Enterococci or Multi-Resistant Gram-Negatives
NCT03250104 ·Status: COMPLETED
-
Infections Caused by ESbL-Producing Enterobacteriaceae in Italy
NCT00404625 ·Status: UNKNOWN
-
Gut Microbiota Association With ESBL-E Colonisation and Subsequent ESBL-E Infection
NCT04131569 ·Status: UNKNOWN
-
Can the Relative Fecal Abundance of BLSE and the Digestive Microbiota be Predictive of the Risk of Infection in a Carrier Patient?
NCT04699981 ·Status: UNKNOWN ·Phase: NA
-
Achromobacter Spp: Description of Epidemiology and Resistance in Chronic Ear Infections and in Healthy Individuals.
NCT04483232 ·Status: UNKNOWN
-
Epidemiological Study of Intestinal Colonization With Staphylococcus Aureus
NCT02547272 ·Status: COMPLETED
-
Detection of Biofilm Among Uropathogenic Escherichia Coli Clinical Isolates in Suez Canal University Hospitals
NCT06252428 ·Status: COMPLETED
-
Deescalating Carbapenems in Hospital Setting
NCT02265445 ·Status: TERMINATED ·Phase: PHASE4
-
Mechanisms of Resistance and Molecular Epidemiology of Commonly Encountered Multi-Resistant Bacteria
NCT00275327 ·Status: COMPLETED
-
Transmission of ESBL-producing Enterobacteriaceae
NCT03465683 ·Status: RECRUITING
-
Impact of Beta-lactams on the Microbiota and Relative Fecal Abundance of Mulltidrug Resistant Bacteria
NCT03338738 ·Status: COMPLETED ·Phase: NA
-
Community - Associated Extended-spectrum Beta-lactamases (ESBL)
NCT00363220 ·Status: COMPLETED
-
Infections and Colonization With the Third Group of Enterobacteriaceae in the Intensive Care Unit
NCT04528043 ·Status: COMPLETED
-
Epidemiology of Community - Associated Extended-spectrum Beta-lactamases (ESBL) Producing Escherichia Coli
NCT00573235 ·Status: COMPLETED
-
Controling Intestinal Colonization With Extended Spectrum ß-Lactamase Producing Enterobacteriaceae ESBL-E
NCT01931592 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Necrotizing External Otitis : Study in a Regional Bone and Joint Infection Reference Center
NCT03768635 ·Status: COMPLETED
-
Clinical and Microbiologic Characteristics of Cephalosporin-Resistant E. Coli-PITT Protocol
NCT00877708 ·Status: COMPLETED
-
A Post-Intervention Surveillance Study Regarding the Acquisition Rate of ESBL-KP, Ecoli
NCT00724919 ·Status: COMPLETED
-
Enterobacteriaceae Producing Extended-spectrum β-lactamases (ESBL) Decolonization Study
NCT00826670 ·Status: COMPLETED ·Phase: PHASE4
-
Combination Treatment for Enterococcus Faecalis Bacteriemia Multicenter, Observational Study"
NCT04070820 ·Status: UNKNOWN
-
Ceftazidime-Avibactam Use in Critically Ill Patients With Carbapenem-Resistant Enterobacteriaceae Infections
NCT05258851 ·Status: TERMINATED ·Phase: PHASE3
-
Prevalence of ESBL-producing Enterobacteriaceae as Carbapenem-resistant Enterobacteriaceae in Nursing Homes.
NCT03248999 ·Status: COMPLETED ·Phase: NA
-
The Association Between Advancing Age and Mortality at 30 Days in Patients With Bacteremia E. Coli Beta-lactamase Phenotype Extended Spectrum RC15_0421
NCT02847065 ·Status: COMPLETED